Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics (Lacidofil) in Alcoholic Hepatitis
NCT02335632Phase 4Unknown
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- Dec 2012
- Primary completion
- Feb 2015
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 4, randomised, double-blind trial of Lacidofil in alcoholic hepatitis (AH) (2 arms), sponsored by Hallym University Chuncheon Sacred Heart Hospital. Primary endpoint: Liver enzymes at 7 days. Status: unknown.
02
Drugs
Lacidofil
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02335632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335632.